The Makovsky Health Practice helps clients successfully navigate complex science, reputation, advocacy, public affairs and marketing priorities with success – always with an eye toward improving patient health. Bringing a deep understanding of the healthcare ecosystem and its many key players, we elevate company visibility and reputation, amplify access to innovation, strengthen relationships, and, ultimately, improve health outcomes.
We provide unmatched research-guided strategy, and achieve client objectives by leveraging targeted media outreach, showcasing thought leadership, preparing issues and crisis management plans, protecting market position, and establishing patient advocacy alliances. As industry leaders, we pursue ground-breaking and purposeful work enabled by our collaborative approach, collective IQ and contagious energy. From direct-to-consumer products to ultra-orphan pharmaceuticals to biotechnology breakthroughs, we work with only two goals in mind: providing exceptional irreplaceable value and, more importantly, improving patient lives.
In order to make a cholesterol drug stand out in a crowded market, we launched a celebrity campaign that brought LIVALO to the forefront.
LIVALO faced the challenge of gaining market share in a saturated space due to the prevalence of generic medications for high cholesterol. LIVALO has distinct advantages for some patients, and needed a champion to break through ingrained prescribing habits.
We partnered with Kurt Warner, two-time National Football League MVP to launch an integrated campaign spanning across online search, medical congresses, traditional media, point-of-care, and a sweepstakes for sustained engagement and CRM opt-ins.
Kowa’s celebrity “Why LIVALO is the right choice” campaign validated patient experiences. Earned media increased by 230% in five months. The campaign website received
46,000 visitors, 7,000 website conversions and 1,900 opt-ins to fuel the CRM database.
In order to establish the organization as a leader and innovator in both medical science and global patient access, we applied our rigorous Thought Leadership approach.
The newly hired Chief Medical Officer, represented an organization-wide shift – bringing the voice of the patient into the board room. The Company wanted to elevate the new CMO’s personal brand, as well as its corporate reputation, as true leaders in their industry.
We conducted research to benchmark CMO leadership and identified opportunities to differentiate the brand. We also developed a database of 100+ venues with proprietary scoring and analysis systems, and a core “Campaign Theme” to drive communications.
In the first year, the CMO spoke at six major conferences and attended multiple forums. This success continued for another four years, with ever-increasing proactive invitations to speak or co-author op-eds, and a 40% open rate for external-facing newsletters.
1775 I Street NW, Suite 1150
Washington, DC 20006
